Published in J Neurochem on March 24, 2014
Differentially expressed and activated proteins associated with non small cell lung cancer tissues. Respir Res (2015) 0.81
Phenylketonuria Pathophysiology: on the Role of Metabolic Alterations. Aging Dis (2015) 0.78
The proteome of methylmalonic acidemia (MMA): the elucidation of altered pathways in patient livers. Mol Biosyst (2016) 0.77
A Specific Nutrient Combination Attenuates the Reduced Expression of PSD-95 in the Proximal Dendrites of Hippocampal Cell Body Layers in a Mouse Model of Phenylketonuria. Nutrients (2016) 0.76
Mass Spectrometry-Based Metabolomic and Proteomic Strategies in Organic Acidemias. Biomed Res Int (2016) 0.75
Biochemical, Metabolic, and Behavioral Characteristics of Immature Chronic Hyperphenylalanemic Rats. Neurochem Res (2015) 0.75
Essential functions of synapsins I and II in synaptic vesicle regulation. Nature (1995) 4.25
Phenylketonuria. Lancet (2010) 3.58
Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature (1995) 2.78
CRMP-2 induces axons in cultured hippocampal neurons. Nat Neurosci (2001) 2.70
Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition (2010) 1.89
The PAH gene, phenylketonuria, and a paradigm shift. Hum Mutat (2007) 1.71
Phenylalanine hydroxylase deficiency. Genet Med (2011) 1.66
Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur J Pharmacol (2006) 1.57
An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels. J Biol Chem (2009) 1.51
Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab (2010) 1.38
Structural bases for CRMP function in plexin-dependent semaphorin3A signaling. EMBO J (2003) 1.29
The synapsins: beyond the regulation of neurotransmitter release. Cell Mol Life Sci (2002) 1.27
White matter pathology in phenylketonuria. Mol Genet Metab (2010) 1.23
Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU. Neuropsychol Rev (2007) 1.21
Structural domains involved in the regulation of transmitter release by synapsins. J Neurosci (2005) 1.19
Nutrition in phenylketonuria. Mol Genet Metab (2011) 1.13
Mice deficient in collapsin response mediator protein-1 exhibit impaired long-term potentiation and impaired spatial learning and memory. J Neurosci (2007) 1.13
Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J Neurochem (2000) 1.11
Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels? Dev Neuropsychol (2007) 1.10
Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis (2009) 1.10
Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease. PLoS One (2012) 1.05
Future treatment strategies in phenylketonuria. Mol Genet Metab (2010) 1.04
Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of life. J Inherit Metab Dis (2012) 1.04
Up to date knowledge on different treatment strategies for phenylketonuria. Mol Genet Metab (2011) 1.02
Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity. Proteomics (2012) 0.96
CRMP3 is required for hippocampal CA1 dendritic organization and plasticity. FASEB J (2007) 0.94
Impaired glutamatergic synaptic transmission in the PKU brain. Mol Genet Metab (2005) 0.93
Phenylalanine reduces synaptic density in mixed cortical cultures from mice. Pediatr Res (2006) 0.90
Animal models of brain dysfunction in phenylketonuria. Mol Genet Metab (2010) 0.89
Follow up of phenylketonuria patients. Mol Genet Metab (2011) 0.88
Biochemical characterization of mutant phenylalanine hydroxylase enzymes and correlation with clinical presentation in hyperphenylalaninaemic patients. J Inherit Metab Dis (2008) 0.88
Neurological complications and behavioral problems in patients with phenylketonuria in a follow-up unit. Mol Genet Metab (2011) 0.87
Oxidative stress in phenylketonuria: what is the evidence? Cell Mol Neurobiol (2011) 0.86
Oxidative stress in a phenylketonuria animal model. Free Radic Biol Med (2002) 0.86
Loss of intellectual function in children with phenylketonuria after relaxation of dietary phenylalanine restriction. Pediatrics (1985) 0.86
Functional and structural characterization of novel mutations and genotype-phenotype correlation in 51 phenylalanine hydroxylase deficient families from Southern Italy. FEBS J (2009) 0.85
Neurological aspects of adult phenylketonuria. Curr Opin Neurol (1998) 0.85
Effects of phenylalanine on the survival and neurite outgrowth of rat cortical neurons in primary cultures: possible involvement of brain-derived neurotrophic factor. Mol Cell Biochem (2010) 0.84
The secretome signature of colon cancer cell lines. J Cell Biochem (2013) 0.84
Cerebral energy metabolism in phenylketonuria: findings by quantitative In vivo 31P MR spectroscopy. Pediatr Res (2003) 0.84
Protein stability and in vivo concentration of missense mutations in phenylalanine hydroxylase. Proteins (2011) 0.84
Genetic deletion of synapsin II reduces neuropathic pain due to reduced glutamate but increased GABA in the spinal cord dorsal horn. Pain (2008) 0.84
Androgen receptor signaling induced by supraphysiological doses of dihydrotestosterone in human peripheral blood lymphocytes. Proteomics (2010) 0.83
Synapsins contribute to the dynamic spatial organization of synaptic vesicles in an activity-dependent manner. J Neurosci (2012) 0.81
PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pah(enu2) mice. Brain Res (2006) 0.81
Glutamatergic neurotransmission in the synapsin I and II double knock-out mouse. Semin Cell Dev Biol (2011) 0.81
Reversal of metabolic and neurological symptoms of phenylketonuric mice treated with a PAH containing helper-dependent adenoviral vector. Curr Gene Ther (2012) 0.81
The formation of synapses in the central nervous system. Mol Neurobiol (2002) 0.80
The effect of blood phenylalanine concentration on Kuvan™ response in phenylketonuria. Mol Genet Metab (2010) 0.80
Response of phenylketonuria to tetrahydrobiopterin. J Nutr (2007) 0.80
Natural phenylalanine hydroxylase variants that confer a mild phenotype affect the enzyme's conformational stability and oligomerization equilibrium. Biochim Biophys Acta (2011) 0.80
Gaining insights into the Bcr-Abl activity-independent mechanisms of resistance to imatinib mesylate in KCL22 cells: a comparative proteomic approach. Biochim Biophys Acta (2010) 0.80
Regionally selective decreases in cerebral glucose metabolism in a mouse model of phenylketonuria. J Inherit Metab Dis (2007) 0.79
Five human phenylalanine hydroxylase proteins identified in mild hyperphenylalaninemia patients are disease-causing variants. Biochim Biophys Acta (2008) 0.78
Molecular epidemiology of phenylalanine hydroxylase deficiency in Southern Italy: a 96% detection rate with ten novel mutations. Ann Hum Genet (2006) 0.77
Expression of Ca2+ channels from rat brain with model phenylketonuria in Xenopus oocytes. Brain Res (1998) 0.76
Genetic modifiers of liver disease in cystic fibrosis. JAMA (2009) 1.88
Combined CD133/CD44 expression as a prognostic indicator of disease-free survival in patients with colorectal cancer. Arch Surg (2012) 1.86
A validated HPLC stability-indicating method for the determination of diacerhein in bulk drug substance. J Pharm Biomed Anal (2005) 1.63
Lessons to be learned from the clinical management of a MEN 2A patient bearing a novel 634/640/700 mutation of the RET proto-oncogene. Clin Endocrinol (Oxf) (2012) 1.60
Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res (2005) 1.57
Identification and functional characterization of malignant hyperthermia mutation T1354S in the outer pore of the Cavalpha1S-subunit. Am J Physiol Cell Physiol (2010) 1.17
AKT participates in endothelial dysfunction in hypertension. Circulation (2004) 1.15
Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity. Antimicrob Agents Chemother (2010) 1.14
An altered gut microbiome profile in a child affected by Crohn's disease normalized after nutritional therapy. Am J Gastroenterol (2013) 1.06
Adiponectin affects lung epithelial A549 cell viability counteracting TNFα and IL-1ß toxicity through AdipoR1. Int J Biochem Cell Biol (2013) 1.01
Potential mechanisms linking atherosclerosis and increased cardiovascular risk in COPD: focus on Sirtuins. Int J Mol Sci (2013) 1.00
BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. Oncogene (2002) 1.00
Butyrate as an effective treatment of congenital chloride diarrhea. Gastroenterology (2004) 0.98
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course. Cancer (2002) 0.98
Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity. Proteomics (2012) 0.96
Haemophilia A: molecular insights. Clin Chem Lab Med (2007) 0.96
Carotid artery remodeling in middle-aged women with the metabolic syndrome (from the "Progetto ATENA" study). Am J Cardiol (2005) 0.94
Identification and characterization of structural domains of human ERp57: association with calreticulin requires several domains. J Biol Chem (2004) 0.94
Adiponectin: an attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD). Nutrients (2013) 0.91
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia. Blood (2003) 0.91
CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo. Cancer (2012) 0.91
Microbial diversity in natural whey cultures used for the production of Caciocavallo Silano PDO cheese. Int J Food Microbiol (2008) 0.91
Decreased paraoxonase-2 expression in human carotids during the progression of atherosclerosis. Arterioscler Thromb Vasc Biol (2008) 0.90
Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with Rab geranylgeranyl transferase. Hum Mutat (2011) 0.90
Distribution of human beta-defensin polymorphisms in various control and cystic fibrosis populations. Genomics (2005) 0.89
Hepatitis B virus reactivation after fludarabine-based regimens for indolent non-Hodgkin's lymphomas: high prevalence of acquired viral genomic mutations. Haematologica (2003) 0.89
Transcription factor TBX1 overexpression induces downregulation of proteins involved in retinoic acid metabolism: a comparative proteomic analysis. J Proteome Res (2009) 0.89
Denaturing HPLC procedure for factor IX gene scanning. Clin Chem (2003) 0.88
Quantitative identification of protein nitration sites. Proteomics (2009) 0.88
Hereditary fructose intolerance: functional study of two novel ALDOB natural variants and characterization of a partial gene deletion. Hum Mutat (2010) 0.87
Interaction proteomics. Biosci Rep (2005) 0.87
SRp20: an overview of its role in human diseases. Biochem Biophys Res Commun (2013) 0.87
Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention. Atherosclerosis (2009) 0.87
Quality of Life (QoL) assessment in a cohort of patients with phenylketonuria. BMC Public Health (2014) 0.86
Bromelain surface modification increases the diffusion of silica nanoparticles in the tumor extracellular matrix. ACS Nano (2014) 0.86
A mannose-binding lectin-defective haplotype is a risk factor for gastric cancer. Clin Chem (2006) 0.86
Functional and structural characterization of novel mutations and genotype-phenotype correlation in 51 phenylalanine hydroxylase deficient families from Southern Italy. FEBS J (2009) 0.85
Structural features of the regulatory ACT domain of phenylalanine hydroxylase. PLoS One (2013) 0.85
Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes. Cytometry A (2012) 0.85
Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injection. Exp Eye Res (2013) 0.85
A paraoxonase gene polymorphism, PON 1 (55), as an independent risk factor for increased carotid intima-media thickness in middle-aged women. Atherosclerosis (2003) 0.85
Haemophilia B: from molecular diagnosis to gene therapy. Clin Chem Lab Med (2003) 0.85
Chimeric beta-defensin analogs, including the novel 3NI analog, display salt-resistant antimicrobial activity and lack toxicity in human epithelial cell lines. Antimicrob Agents Chemother (2013) 0.85
Structural and functional analysis of aldolase B mutants related to hereditary fructose intolerance. FEBS Lett (2002) 0.84
Six novel alleles identified in Italian hereditary fructose intolerance patients enlarge the mutation spectrum of the aldolase B gene. Hum Mutat (2004) 0.84
Differential proteomic analysis in human cells subjected to ribosomal stress. Proteomics (2013) 0.84
The secretome signature of colon cancer cell lines. J Cell Biochem (2013) 0.84
Recombinant amyloidogenic domain of ApoA-I: analysis of its fibrillogenic potential. Biochem Biophys Res Commun (2006) 0.84
Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian Project on Standardisation and Quality Assurance. Clin Chem Lab Med (2004) 0.83
Functional analysis of melanocortin-4-receptor mutants identified in severely obese subjects living in Southern Italy. Gene (2010) 0.83
Androgen receptor signaling induced by supraphysiological doses of dihydrotestosterone in human peripheral blood lymphocytes. Proteomics (2010) 0.83
Direct detection of exon deletions/duplications in female carriers of and male patients with Duchenne/Becker muscular dystrophy. Clin Chem (2004) 0.83
Analysis of transglutaminase protein substrates by functional proteomics. Protein Sci (2003) 0.83
Proteomic Profiling of a Biomimetic Drug Delivery Platform. Curr Drug Targets (2015) 0.83
Surface proteomic analysis of differentiated versus stem-like osteosarcoma human cells. Proteomics (2013) 0.82
The first case of mitochondrial acetoacetyl-CoA thiolase deficiency identified by expanded newborn metabolic screening in Italy: the importance of an integrated diagnostic approach. J Inherit Metab Dis (2010) 0.82
Adiponectin in asthma: implications for phenotyping. Curr Protein Pept Sci (2015) 0.82
Adiponectin as novel regulator of cell proliferation in human glioblastoma. J Cell Physiol (2014) 0.81
Adiponectin oligomers as potential indicators of adipose tissue improvement in obese subjects. Eur J Endocrinol (2013) 0.81
l-Lactate metabolism in HEP G2 cell mitochondria due to the l-lactate dehydrogenase determines the occurrence of the lactate/pyruvate shuttle and the appearance of oxaloacetate, malate and citrate outside mitochondria. Biochim Biophys Acta (2012) 0.81
Reversal of metabolic and neurological symptoms of phenylketonuric mice treated with a PAH containing helper-dependent adenoviral vector. Curr Gene Ther (2012) 0.81
Gaining insights into the Bcr-Abl activity-independent mechanisms of resistance to imatinib mesylate in KCL22 cells: a comparative proteomic approach. Biochim Biophys Acta (2010) 0.80
Multistage Nanovectors Enhance the Delivery of Free and Encapsulated Drugs. Curr Drug Targets (2015) 0.80
Identification of new polymorphisms in the CACNA1S gene. Clin Chem Lab Med (2003) 0.80
Altered expression of inflammation-related genes in human carotid atherosclerotic plaques. Atherosclerosis (2011) 0.80
Phenotypic expression of genotype-phenotype correlation in cystic fibrosis patients carrying the 852del22 mutation. Am J Med Genet A (2005) 0.80
Natural phenylalanine hydroxylase variants that confer a mild phenotype affect the enzyme's conformational stability and oligomerization equilibrium. Biochim Biophys Acta (2011) 0.80
ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells. Mol Cancer (2014) 0.80
Quantitative liquid chromatography coupled with tandem mass spectrometry analysis of urinary acylglycines: application to the diagnosis of inborn errors of metabolism. Anal Biochem (2011) 0.79
Citrulline blood levels as indicators of residual intestinal absorption in patients with short bowel syndrome. Ann Nutr Metab (2008) 0.79
Functional characterization of ryanodine receptor (RYR1) sequence variants using a metabolic assay in immortalized B-lymphocytes. Hum Mutat (2009) 0.79
Serum withdrawal after embryoid body formation does not impair cardiomyocyte development from mouse embryonic stem cells. Cytotherapy (2010) 0.78
Targeted metabolomics in the expanded newborn screening for inborn errors of metabolism. Mol Biosyst (2015) 0.78
Unraveling the structural and functional features of an aldolase A mutant involved in the hemolytic anemia and severe rhabdomyolysis reported in a child. Blood (2005) 0.78
Should a BRCA2 stop codon human variant, usually considered a polymorphism, be classified as a predisposing mutation? Cancer (2014) 0.78
Functional proteomics. Clin Chim Acta (2005) 0.78
Insulin-like growth factor 1 receptor signaling induced by supraphysiological doses of IGF-1 in human peripheral blood lymphocytes. Proteomics (2014) 0.78
Serum from humans on long-term calorie restriction enhances stress resistance in cell culture. Aging (Albany NY) (2013) 0.78
Five human phenylalanine hydroxylase proteins identified in mild hyperphenylalaninemia patients are disease-causing variants. Biochim Biophys Acta (2008) 0.78
Complex formation between Zn2+ ion and 1,3-bis[bis(pyridin-2-ylmethyl)amino]propan-2-ol. Ann Chim (2006) 0.78
Purification and characterization of a small (7.3 kDa) putative lipid transfer protein from maize seeds. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 0.78
Human aldolase A natural mutants: relationship between flexibility of the C-terminal region and enzyme function. Biochem J (2004) 0.78
Child neurology: Recurrent rhabdomyolysis due to a fatty acid oxidation disorder. Neurology (2014) 0.77
Prenatal diagnosis of inherited diseases: 20 years' experience of an Italian Regional Reference Centre. Clin Chem Lab Med (2013) 0.77
Prenatal diagnosis of cystic fibrosis: an experience of 181 cases. Clin Chem Lab Med (2013) 0.77
A 15-year case-mix experience for fragile X syndrome molecular diagnosis and comparison between conventional and alternative techniques leading to a novel diagnostic procedure. Clin Chim Acta (2012) 0.77
A larger spectrum of intragenic short tandem repeats improves linkage analysis and localization of intragenic recombination detection in the dystrophin gene: an analysis of 93 families from southern Italy. J Mol Diagn (2007) 0.77
The effect of prime-site occupancy on the hepatitis C virus NS3 protease structure. Protein Sci (2002) 0.77
Cystic fibrosis presenting as metabolic alkalosis in a boy with the rare D579G mutation. J Cyst Fibros (2004) 0.77
Novel deletion mutation in the cardiac sodium channel inactivation gate causes long QT syndrome. Int J Cardiol (2012) 0.77
Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats. Protein Sci (2003) 0.77